Guggenheim Capital’s Rennova Health, Inc. RNVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,188
Closed -$3K 2919
2017
Q3
$3K Buy
+1,188
New +$5.08K ﹤0.01% 2798

Guggenheim Capital's RNVA Position: Q4 2017 in Review

Guggenheim Capital sold out of Rennova Health, Inc. (RNVA) in Q4 2017, closing a stake of 1,188 shares — an estimated $3K sold.

Guggenheim Capital first reported a position in RNVA in Q3 2017 and held it in 1 quarter. The position peaked at $3K in Q3 2017. 1 fund tracked by Wall St. Rank holds RNVA as of Q4 2017.

  • Guggenheim Capital reported no remaining Rennova Health, Inc. position as of Q4 2017 after selling out during the quarter.
  • Guggenheim Capital sold 1,188 Rennova Health, Inc. shares in Q4 2017, an estimated $3K.
  • Guggenheim Capital first reported a position in Rennova Health, Inc. in Q3 2017 and held it in 1 quarter.
  • Guggenheim Capital's Rennova Health, Inc. position peaked at $3K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Rennova Health, Inc. as of Q4 2017.

Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.